TKUNF (Tikun Olam Cannbit Pharmaceuticals) ROCE %: 0.00% (As of Dec. 2025)


TKUNF Tikun Olam Cannbit Pharmaceuticals Ltd TKUNF
4 GF Score
Price $6.00
GF Value $2.49
! 6 Warning Signs
View Full Analysis

What is Tikun Olam Cannbit Pharmaceuticals ROCE %?

Tikun Olam Cannbit Pharmaceuticals TKUNF 4 ROCE % is 0.00% as of Dec. 2025. GuruFocus rates TKUNF with a GF Score™ of 4/100 and a GF Value™ of $2.49. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tikun Olam Cannbit Pharmaceuticals's annualized ROCE % for the quarter that ended in Dec. 2025 was 0.00%.

Tikun Olam Cannbit Pharmaceuticals  (OTCPK:TKUNF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tikun Olam Cannbit Pharmaceuticals ROCE % Related Terms

Tikun Olam Cannbit Pharmaceuticals ROCE % Historical Data

* Premium members only.

The historical data trend for Tikun Olam Cannbit Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tikun Olam Cannbit Pharmaceuticals ROCE % Chart

Tikun Olam Cannbit Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.44 -19.54 -31.96 -103.11 -146.13

Tikun Olam Cannbit Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -75.52 -170.38 -198.14 0.00 0.00
TKUNF
4GF Score
Tikun Olam Cannbit Pharmaceuticals Ltd TKUNF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tikun Olam Cannbit Pharmaceuticals ROCE % Calculation

Tikun Olam Cannbit Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-12.896/( ( (25.837 - 9.559) + (8.1 - 6.728) )/ 2 )
=-12.896/( (16.278+1.372)/ 2 )
=-12.896/8.825
=-146.13 %

Tikun Olam Cannbit Pharmaceuticals's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-0.676/( ( (2.644 - 6.882) + (0.505 - 7.027) )/ 2 )
=-0.676/( ( -4.238 + -6.522 )/ 2 )
=-0.676/-5.38
=0 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Tikun Olam Cannbit Pharmaceuticals (TKUNF) has a ROCE % of 0.00% as of Dec. 2025.
Is Tikun Olam Cannbit Pharmaceuticals' ROCE % too high?
Tikun Olam Cannbit Pharmaceuticals' current ROCE % is 0.00%. Overall, Tikun Olam Cannbit Pharmaceuticals has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Tikun Olam Cannbit Pharmaceuticals' ROCE % compare to ZTS and UTHR?
Tikun Olam Cannbit Pharmaceuticals' ROCE % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tikun Olam Cannbit Pharmaceuticals's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tikun Olam Cannbit Pharmaceuticals stock overvalued right now?
Tikun Olam Cannbit Pharmaceuticals (TKUNF) has a current ROCE % of 0.00%. The stock's GF Value™ is $2.49, compared to a current price of $6.00 — trading 141% above its estimated fair value. The current ROCE % is 0.00%. Tikun Olam Cannbit Pharmaceuticals' overall GF Score™ is 4/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Tikun Olam Cannbit Pharmaceuticals (TKUNF), the current ROCE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tikun Olam Cannbit Pharmaceuticals (TKUNF) Overvalued in 2026?

Based on GuruFocus' analysis, Tikun Olam Cannbit Pharmaceuticals stock appears to be overvalued. The current stock price of $6.00 is trading 141% above its estimated GF Value™ of $2.49.

Key valuation signals for TKUNF:

  • ROCE %: 0.00%
  • GF Value™: $2.49 vs. price of $6.00 (141% above fair value)
  • GF Score™: 4/100 with 6 warning signs

No single metric tells the full story. See the TKUNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tikun Olam Cannbit Pharmaceuticals Business Description

Other Exchanges TKUN:Israel
Address The Fourteenth, Tel Aviv, ISR
Tikun Olam Cannbit Pharmaceuticals Ltd is engaged in the business of growing and marketing medical cannabis.
4GF Score

Get the complete analysis for TKUNF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.00
Price
$2.49
GF Value